* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Rajiv Gandhi University Of Health Sciences, Karnataka Bangalore
Remote ischemic conditioning wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Coronary artery disease wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Echocardiography wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, KARNATAKA BANGALORE. ANNEXURE- II PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERTATION NAME OF THE CANDIDATE AND ADDRESS (IN BLOCK LETTERS) DR.VINAY M DIPALI 2. NAME OF THE INSTITUTION KARNATAKA INSTITUTE OF MEDICAL SCIENCES,HUBLI-22. 3. COURSE OF STUDY AND SUBJECT M.D. IN GENERAL MEDICINE. 4. DATE OF ADMISSION TO COURSE 5. TITLE OF THE TOPIC 1. 6. POST GRADUATE IN GENERAL MEDICINE, KARNATAKA INSTITUTE OF MEDICAL SCIENCES, HUBLI-580022. 15-05-2009 CORRELATION OF ELECTROCARDIOGRAPHY AND ECHOCARDIOGRAPHY IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY BRIEF RESUME OF THE INTENDED WORK: 6.1 NEED FOR STUDY: There is an increased risk of cardiac morbidity and mortality associated with left ventricular hypertrophy (LVH), so its detection is of major importance, especially for individuals with hypertension or other cardiovascular risk factors. LVH is no longer considered an adaptive process that compensates the pressure imposed on the heart and has been identified as an independent and significant risk factor for sudden death, acute myocardial infarction, and congestive heart failure. The increase in left ventricular mass represents a common final pathway towards the adverse effects on the cardiovascular system and higher vulnerability to complications. Electrocardiographic evidence of left ventricular hypertrophy is one of the most widely used markers of cardiovascular morbidity and mortality. It has become a clinical priority to precociously detect left ventricular hypertrophy by effective, low-cost screening, applicable to the population in general. ECG is relatively insensitive and cannot accurately quantitate the severity of LVH. Also LVH is difficult to diagnose by ECG if left bundle branch block is present. Because of these limitations, other diagnostic modalities have been used for LVH assessment. The most successful and popular of these techniques has been echocardiography. Echocardiography has revolutionized the diagnosis of LVH because echocardiographic evidence of LVH occurs in 30 to 40 percent of hypertensive patients whose ECG and chest X-ray are normal. 6.2 REVIEW OF THE LITERATURE: 1) Mia M R, A R M Saifuddin Ekram , Haque M A,Raisuddin in their study of 100 cases in random manner concluded that ECG is very sensitive (90%) but less specific (20- 60%) in diagnosing left ventricular hypertrophy.They also found that out of 80 patients having ECG-LVH, echocardiographic evidence of LVH was found in 70 of them. The specificity of ECG criteria in this study was 50%, which is consistent with various other studies. Sensitivity of ECG in comparison to Echocardiography was calculated to be 87.50% which is consistent with various other studies. Sensitivity of ECG to diagnose LVH was found to be 87.5%, and specificity was only 50%. ECG is relatively insensitive and cannot accurately identify the severity of LVH. 2) Hameed W et al, in their study of fifty clinically diagnosed patients of LVH found that ECG had a sensitivity of 35% and specificity 90% and they concluded that the sensitivity of ECG is low in detecting LVH as compared to echocardiography. However the sensitivity of ECG to detect LVH can be increased by adding Cornell Voltage criteria and Sokolow Lyons voltage criteria to RomhiltEstes pointscore system. 3) Okin P M et al,in their study of ECGs and echocardiograms of 2193 patients,Echo-LVH and ECG-STD predicted CV(cardiovascular) and AC(all cause) mortality, respectively. The combination of Echo-LVH and ECG-STD improved risk stratification compared with either alone for both CV death and AC death , with presence of both ECG-STD and Echo-LVH associated with the greatest risks. After adjustment for age, sex, and relevant risk factors, combined Echo-LVH and ECG-STD remained predictive of CV mortality and AC mortality, with the presence of both EchoLVH and ECG-STD associated with a 6.3-fold increased risk of CV death (95% CI: 2.8 to 14.2) and a 4.6-fold increased risk of AC mortality (95% CI: 2.5 to 8.5). ECG-STD and Echo-LVH additively increase the risk of both CV mortality and AC mortality. Their findings supported the value of combining Echo-LVH and ECG-STD to improve risk stratification. 4) R. B. Devereux et al in their study of “Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease” showed that the sensitivity of echocardiography to detect LVH has been reasonably high (85–100%), whereas that of ECG has ranged from as high as 50% in severely diseased necropsy populations to as low as 6–17% in recent studies in Cornell and Framingham. ECG sensitivity can be improved by using Cornell multivariate regression equations or by consideration of the Cornell voltage-QRS duration product. Obesity dramatically decreases the sensitivity of the ECG for detection of LVH, and recent research suggests a lower specificity and a higher rate of false-positive ECG diagnoses of LVH in black than in white subjects. Standard criteria for ECG LVH are less useful than echocardiographic findings for stratifying populations into high- and low-risk subgroups because of lower sensitivity. 5) N Reichek and RB Devereux studied the Anatomic, echocardiographic and ECG findings of left ventricular hypertrophy (LVH) in 34 subjects. Echocardiographic LV mass correlated well with postmortem LV weight (r = 0.96) and accurately diagnosed LVH (sensitivity 93%, specificity 95%). In contrast, Romhilt-Estes (RE) point score and Sokolow-Lyon (SL) voltage criteria for ECG LVH were insensitive (50% and 21%, respectively) but specific (both 95%). RE correlated weakly with LV weight (r = 0.64), but SL did not.They concluded that the ECG is specific but insensitive ill recognition of LVH. M-mode echocardiographic LV mass is superior to ECG criteria for clinical diagnosis of LVH. 6.3 AIMS AND OBJECTIVES OF THE STUDY: 1. To determine the electrocardiographic and echocardiographic evidence of LVH. 2. 2. To correlate the electrocardiographic and echocardiographic evidence of LVH in patients with various etiologies of LVH. 7. MATERIALS AND METHODS : 7.1 SOURCE OF DATA: A total of 100 patients from those attending medicine OPD and getting admitted medicine ward,KIMS hospital,Hubli, during the period of December 1st 2009 to November 30th 2010 will be taken for study considering the inclusion and exclusion criteria. 7.2 METHODS OF COLLECTION OF DATA: 1)Information will be collected through a pre tested and structured proforma for each patient. 2) Qualifying patients will be undergoing detailed history, clinical examination,12-lead ECG and 2-Dechocardiography. SAMPLE SIZE:A Total of 100 patients after considering inclusion and exclusion criteria will be taken up for study. TYPE OF STUDY:CROSS SECTIONAL HOSPITAL BASED TIME BOUND STUDY. SAMPLING:As per hospital statistics 10000 patients were admitted in Department of Medicine, KIMS, Hubli in the year 2008. Of them 900 patients were diagnosed to have LVH. This gives a prevalence of 9% With confidence interval of 95% and 5% permissible error, sample size comes out to be 100 cases. However this being a time bound study (December 1st 2009 to 30th November 2010), all the patients presenting with LVH in Medicine Department,KIMS Hospital during this period will be taken for the study. Inclusion criteria : All patients presenting to OPD and admitted in Medicine ward,KIMS Hospital HUBLI,with history and Clinical profile suggestive of cardiac morbidities leading to LVH as mentioned below and confirmed by 2-D echocardiography will be included in the study. 1)Essential Hypertension. 2)Mitral and Aortic Regurgitation,Aortic Stenosis. 3)Coarctation of aorta,VSD Exclusion criteria: -Ischemic Heart disease -Bundle Branch Blocks Parameters used:clinical profile, 12-lead ECG changes,2-D echo findings. Statistical Analysis:percentages,proportions,chi-square,correlation. 7.3 Does the study require any investigations or interventions to be conducted on patients or other humans or animals? (If so, please describe briefly) Yes, 1) Routine blood investigations 2) ECG 3) 2-D ECHO 7.4 Has ethical clearance been obtained from ethical committee of your institution in case of 7.3? Yes, ethical clearance has been obtained from the ethical committee KIMS, Hubli. 8. LIST OF REFERENCES: 1) M Razzak Mia , A R M Saifuddin Ekram , M Azizul Haque , Raisuddin; A Comparative Study of Electrocardiographic and Echocardiographic Evidence of Left ventricular Hypertrophy; TAJ 2007; 20(1): 24-27. 2)Waqas Hameed et al,ELECTROCARDIOGRAPHIC DIAGNOSIS OF LEFT VENTRICULAR HYPERTROPHY: COMPARISON WITH ECHOCARDIOGRAPHY; Pak J Physiol 2005;1(1-2). 3)Peter M. Okin et al, Combined Echocardiographic Left Ventricular Hypertrophy and Electrocardiographic ST Depression Improve Prediction of Mortality in American Indians The Strong Heart Study; Hypertension 2004;43;769-774; 4) R. B. Devereux et al,Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease; European Heart Journal 1993 14(Supplement D):8-15; 5) N Reichek and RB Devereux;Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings;Circulation;1981;63;1391-1398. 9. Signature of the candidate 10. Remarks of the guide 11. Name and Designation 11.1 Guide DR.ISHWAR HASABI. ASSOCIATE PROFESSOR, DEPARTMENT OF MEDICINE KIMS, HUBLI. 11.2 Signature 11.3 Co-Guide 11.4 Signature 11.5 Head of the Department 11.6 Signature 12. 12.1 Remarks of the Principal and Chairman 12.2 Signature Dr. H. MALLIKARJUN SWAMY. PROFESSOR AND HEAD, DEPARTMENT OF MEDICINE KIMS, HUBLI.